298 related articles for article (PubMed ID: 36645398)
1. What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R; Siadat F; Trpkov K
Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
[TBL] [Abstract][Full Text] [Related]
2. The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates.
Goswami PR; Singh G; Patel T; Dave R
Cureus; 2024 Apr; 16(4):e58470. PubMed ID: 38765391
[TBL] [Abstract][Full Text] [Related]
3. New insights in the new WHO classification of adult renal tumors.
Hes O; Michalová K; Pivovarčíková K
Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
[TBL] [Abstract][Full Text] [Related]
4. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H; Amin MB; Berney DM; Compérat EM; Gill AJ; Hartmann A; Menon S; Raspollini MR; Rubin MA; Srigley JR; Hoon Tan P; Tickoo SK; Tsuzuki T; Turajlic S; Cree I; Netto GJ
Eur Urol; 2022 Nov; 82(5):458-468. PubMed ID: 35853783
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification.
Rizzo M; Caliò A; Brunelli M; Pezzicoli G; Ganini C; Martignoni G; Camillo P
Cancer Treat Rev; 2023 May; 116():102558. PubMed ID: 37060647
[TBL] [Abstract][Full Text] [Related]
6. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
[TBL] [Abstract][Full Text] [Related]
7. Kidney Tumors: New and Emerging Kidney Tumor Entities.
Siadat F; Mansoor M; Hes O; Trpkov K
Clin Lab Med; 2023 Jun; 43(2):275-298. PubMed ID: 37169446
[TBL] [Abstract][Full Text] [Related]
8. Kidney Tumors: New and Emerging Kidney Tumor Entities.
Siadat F; Mansoor M; Hes O; Trpkov K
Surg Pathol Clin; 2022 Dec; 15(4):713-728. PubMed ID: 36344185
[TBL] [Abstract][Full Text] [Related]
9. The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges.
Mohanty SK; Lobo A; Cheng L
Hum Pathol; 2023 Jun; 136():123-143. PubMed ID: 36084769
[TBL] [Abstract][Full Text] [Related]
10. Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
Udager AM; Mehra R
Arch Pathol Lab Med; 2016 Oct; 140(10):1026-37. PubMed ID: 27684973
[TBL] [Abstract][Full Text] [Related]
11. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract][Full Text] [Related]
12. [International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012].
Hes O
Cesk Patol; 2014; 50(4):137-41. PubMed ID: 25418900
[TBL] [Abstract][Full Text] [Related]
13. The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
Kanakaraj J; Chang J; Hampton LJ; Smith SC
Urol Oncol; 2024 Jul; 42(7):211-219. PubMed ID: 38519377
[TBL] [Abstract][Full Text] [Related]
14. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H; Cubilla AL; Humphrey PA; Reuter VE; Ulbright TM
Eur Urol; 2016 Jul; 70(1):93-105. PubMed ID: 26935559
[TBL] [Abstract][Full Text] [Related]
15. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
[TBL] [Abstract][Full Text] [Related]
16. Chromophobe renal cell carcinoma: current and controversial issues.
Moch H; Ohashi R
Pathology; 2021 Jan; 53(1):101-108. PubMed ID: 33183792
[TBL] [Abstract][Full Text] [Related]
17. LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.
Samaratunga H; Egevad L; Thunders M; Iczskowski KA; van der Kwast T; Kristiansen G; Pan CC; Leite KRM; Evans A; Clouston D; Kenwright DN; Bethwaite PB; Malone G; Wood S; Yaxley JW; Delahunt B
Pathology; 2022 Dec; 54(7):842-847. PubMed ID: 36270849
[TBL] [Abstract][Full Text] [Related]
18.
Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic Solid and Cystic Renal Cell Carcinoma: From Unclassified to Classified, A Case Report.
Sharma R; Thirunavukkarasu B; Elhence P; Rodha MS; Sureka B
Turk Patoloji Derg; 2022; 38(1):60-65. PubMed ID: 34514562
[TBL] [Abstract][Full Text] [Related]
20. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
Chen YB
Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
